BeyondSpring (BYSI) Form 3 BeyondSpring / Matthew Kirkby ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Kirkby Matthew

(Last) (First) (Middle)

C/O BEYONDSPRING INC., 100 CAMPUS DRIVE

WEST SIDE, 4TH FLOOR, SUITE 410

(Street)

FLORHAM PARK NJ 07932

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/31/2024

3. Issuer Name and Ticker or Trading Symbol
BeyondSpring Inc. [ BYSI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	(1)	08/01/2030	Ordinary Shares	5,000	11.03(1)	D
Stock Options (right to buy)	(2)	01/01/2031	Ordinary Shares	10,000	12.2(2)	D
Stock Options (right to buy)	(3)	01/01/2032	Ordinary Shares	10,000	4.53(3)	D
Stock Options (right to buy)	(4)	03/07/2032	Ordinary Shares	10,000	1.99(4)	D
Stock Options (right to buy)	(5)	02/10/2033	Ordinary Shares	15,000	2.68(5)	D
Stock Options (right to buy)	(6)	05/08/2033	Ordinary Shares	25,000	0.9835(6)	D
Stock Options (right to buy)	(7)	12/18/2033	Ordinary Shares	19,875	0.99(7)	D
Stock Options (right to buy)	(8)	01/01/2034	Ordinary Shares	10,000	0.9(8)	D

Explanation of Responses:

1. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 5,000 stock options are fully vested and exercisable.

2. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 10,000 stock options are fully vested and exercisable.

3. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 10,000 stock options are fully vested and exercisable.

4. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 10,000 stock options are fully vested and exercisable.

5. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 15,000 stock options are fully vested and exercisable.

6. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 25,000 stock options are fully vested and exercisable.

7. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 19,875 stock options are fully vested and exercisable.

8. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. None of the stock options have become fully vested and exercisable. 10,000 of the stock options will vest on January 1, 2025.

Remarks:

As the Company no longer qualifies as a foreign private issuer, effective January 1, 2025, the Company's officers, directors, and principal shareholders are subject to Section 16 of the Securities Exchange Act of 1934 ("Exchange Act"). Previously, the Company determined that it qualified as a foreign private issuer under the Exchange Act.

	/s/ Matthew Kirkby	12/31/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.